Valery Walker

1.4k citations

40 papers · 1.1k indexed · h-index 16

Impact in

Hepatology top 2%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies

Papers in ⓘ

Health Informatics 1
Rheumatology 9
- Rheumatoid Arthritis Research and Therapies 6
- Osteoarthritis Treatment and Mechanisms 6

Co-authors: George W. Torrance (7 shared papers)Charlie H. Goldsmith (5 shared papers)Nicholas Bellamy (8 shared papers)Peter Tugwell (8 shared papers)J.-P. Raynauld (3 shared papers)M. Schultz (4 shared papers)Philip A. Band (4 shared papers)Lawrence Worobetz (1 shared paper)
Journals: Journal of Managed Care & Specialty Pharmacy (4 papers)Osteoarthritis and Cartilage (4 papers)PharmacoEconomics (2 papers)Annals of the Rheumatic Diseases (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)
Partner nations: United States Canada Australia

In The Last Decade

Valery Walker

39 papers receiving 1.0k citations

Peers

Countries citing papers authored by Valery Walker

Since Specialization

Citations

This map shows the geographic impact of Valery Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valery Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valery Walker more than expected).

Fields of papers citing papers by Valery Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valery Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valery Walker. The network helps show where Valery Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Valery Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Valery Walker Line = papers co-authored together Valery Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology ·E. Jenny Heathcote, Karen Cauch‐Dudek, Valery Walker, Robert J. Bailey, Laurence M. Blendis, Cameron N. Ghent, Pina Michieletti, Gerald Y. Minuk, S. Chris Pappas, Linda Scully, Urs P. Steinbrecher, Lloyd R. Sutherland, C. N. Williams, Helga Witt-Sullivan, Lawrence Worobetz, Ruth Milner, Ian R. Wanless	1994	342
2	A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results Osteoarthritis and Cartilage ·J.-P. Raynauld, George W. Torrance, Philip A. Band, Charlie H. Goldsmith, Peter Tugwell, Valery Walker, M. Schultz, Nicholas Bellamy	2002	193
3	The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review Annals of the Rheumatic Diseases ·Claire Bombardier, Marco Barbieri, Anju Parthan, Debra Zack, Valery Walker, David Macarios, Josef S Smolen	2011	79
4	A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results Osteoarthritis and Cartilage ·George W. Torrance, J.-P. Raynauld, Valery Walker, Charlie H. Goldsmith, Nicholas Bellamy, Philip A. Band, M. Schultz, Peter Tugwell	2002	67
5	Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Elizabeth Dodds Ashley, Richard H. Drew, Melissa D. Johnson, Robert P. Danna, Dominika Dabrowski, Valery Walker, Manishi Prasad, Barbara D. Alexander, George Papadopoulos, John R. Perfect	2012	55
6	Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis Annals of the Rheumatic Diseases ·Nicholas Bellamy, Mary Bell, Charlie H. Goldsmith, Dan Pericak, Valery Walker, J.-P. Raynauld, George W. Torrance, Peter Tugwell, (unknown)	2004	50
7	Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year PharmacoEconomics ·George W. Torrance, Valery Walker, Ronald F. Grossman, Jayanti Mukherjee, David Vaughan, Jacques La Forge, Noël Lampron	1999	36
8	A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD) Annals of Allergy Asthma & Immunology ·Wenhui Wei, Eric Ghorayeb, Michael Andria, Valery Walker, James Schnitzer, Martha Kennedy, Zhen Chen, Angela Belland, John White, Jonathan I. Silverberg	2019	34
9	The Burden of Illness in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease in Canada Canadian Respiratory Journal ·M. Reza Maleki-Yazdi, Suzanne M. Kelly, Sy Lam, Mihaela Marin, M Barbeau, Valery Walker	2012	26
10	Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting Patient Preference and Adherence ·Aki Shiozawa, Puja Khanna, Valery Walker, Tim Bancroft, Breanna Essoi, Kasem S. Akhras, Dinesh Khanna	2015	25
11	The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI Osteoarthritis and Cartilage ·Nicholas Bellamy, Mary Bell, Charlie H. Goldsmith, Dan Pericak, Valery Walker, Jean‐Pierre Raynauld, George W. Torrance, Peter Tugwell, Richard P. Polisson	2005	25
12	Successful Discontinuation of Systemic Opioids After Implantation of an Intrathecal Drug Delivery System Neuromodulation Technology at the Neural Interface ·David Caraway, Valery Walker, Laura Becker, Jennifer Hinnenthal	2015	22
13	Cost-effectiveness of Apligraf in the treatment of venous leg ulcers. PubMed ·R. Gary Sibbald, G W Torrance, Valery Walker, C Attard, P MacNeil	2001	21
14	BLISS index for analyzing knee osteoarthritis trials data Journal of Clinical Epidemiology ·Nicholas Bellamy, Mary Bell, Dan Pericak, Charlie H. Goldsmith, George W. Torrance, Jean‐Pierre Raynauld, Valery Walker, Peter Tugwell, Richard P. Polisson	2006	20
15	Health-Related Quality of Life in Patients With Major Depression Who Are Treated With Moclobemide Journal of Clinical Psychopharmacology ·Valery Walker, David L. Streiner, Snezana Novosel, Angela Rocchi, Mitchell Levine, Deanne M. Dean	1995	18
16	Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program Current Medical Research and Opinion ·Αλεξάνδρα Παπαϊωάννου, Aliya Khan, André Bélanger, W. Bensen, David L. Kendler, Francois Theoret, Mo Amin, Lee Brekke, Michelle Erdmann, Valery Walker, Jonathan D. Adachi	2015	17
17	Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS PharmacoEconomics ·Anita Rachlis, Fiona Smaill, Valery Walker, Lorraine Hotchkies, Amy Jones	1999	6
18	Association Between Cognitive Function and Health Care Costs 3 Months and 6 Months After Initiating Antidepressant Medication for Depressive Disorders Journal of Managed Care & Specialty Pharmacy ·Valery Walker, Haridarshan Patel, Jonathan Kurlander, Breanna Essoi, Jiao Yang, Atul R. Mahableshwarkar, Jennifer C. Samp, Kasem S. Akhras	2015	6
19	Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporosis International ·Jonathan D. Adachi, Courtney Kennedy, Αλεξάνδρα Παπαϊωάννου, George Ioannidis, William D. Leslie, Valery Walker	2009	6
20	<p>Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD</p> International Journal of COPD ·Charlie Strange, Valery Walker, Michael DePietro, Junliang Tong, Jonathan Kurlander, Maureen Carlyle, Lauren A. Millette, Eric Wittbrodt	2019	5

About Valery Walker

Valery Walker is a scholar working on Health Informatics, Rheumatology, Pharmacology, Orthopedics and Sports Medicine and Dermatology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Respiratory Support and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Schizophrenia research and treatment (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). The work is most often cited by research in Hepatology (323 citations), Rheumatology (374 citations), Epidemiology (346 citations), Pharmacology (160 citations) and Orthopedics and Sports Medicine (70 citations). Valery Walker has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include George W. Torrance, Charlie H. Goldsmith, Nicholas Bellamy, Peter Tugwell, J.-P. Raynauld, M. Schultz, Philip A. Band, Lawrence Worobetz, Karen Cauch‐Dudek and Linda Scully. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Osteoarthritis and Cartilage, PharmacoEconomics, Annals of the Rheumatic Diseases and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact